Atlas Trials

A Study to Assess the Mass Balance of [14C] ABBV-903 in Healthy Male Participants Following Single Oral Dose Administration

Clinical trial NCT05995366 · COMPLETED

Trial details

NCT number
NCT05995366
Sponsor
AbbVie
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteer
Start date
2023-08-18
Primary completion
2023-10-13
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.